Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Part 1
\- Healthy men and women of non-childbearing potential, 18 to 80 years of age inclusive, and in good health as determined by past medical history, physical examination, vital signs, electrocardiogram, and laboratory tests at screening.
Part 2
Hypertensive men and women of non-childbearing potential, 18 to 80 years of age inclusive.
Patients with mild-to-moderate uncomplicated essential hypertension
You may not be if
Part 1
History of hypersensitivity or allergy to any of the study drugs or to drugs of similar chemical classes.
A history of clinically significant ECG abnormalities.
Known history or current clinically significant arrhythmias.
History of hypertension, adrenal or endocrine disease.
Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test.
Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant.
Smokers (use of tobacco products in the previous 3 months).
History of immunodeficiency diseases, including a positive HIV (ELISA and Western blot) test result.
A positive Hepatitis B surface antigen or Hepatitis C test result.
Part 2
Pregnant or nursing (lactating) women.
Women of child-bearing potential.
Known history or evidence of a secondary form of hypertension
Type 1 or type 2 diabetes mellitus.
History of heart diseases
A positive Hepatitis B surface antigen (HBsAg) or Hepatitis C test result.
History of immunodeficiency diseases, including a positive HIV (ELISA and Western blot) test result.
